These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8743725)

  • 1. Ex-vivo and in-vivo platelet function in patients with severe hypercholesterolemia undergoing LDL-apheresis.
    Sinzinger H; Pirich C; Bednar J; O'Grady J
    Thromb Res; 1996 May; 82(4):291-301. PubMed ID: 8743725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of selective LDL-apheresis and pravastatin therapy on platelet function in familial hypercholesterolaemia.
    Bröijersén A; Eriksson M; Larsson PT; Beck O; Berglund L; Angelin B; Hjemdahl P
    Eur J Clin Invest; 1994 Jul; 24(7):488-98. PubMed ID: 7957507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: antiatherogenic effects of HMG-CoA reductase inhibitor therapy.
    Aviram M; Hussein O; Rosenblat M; Schlezinger S; Hayek T; Keidar S
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):39-45. PubMed ID: 9456275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia.
    Nofer JR; Tepel M; Kehrel B; Wierwille S; Walter M; Seedorf U; Zidek W; Assmann G
    Circulation; 1997 Mar; 95(6):1370-7. PubMed ID: 9118502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet hyperactivity after statin treatment discontinuation.
    Puccetti L; Pasqui AL; Pastorelli M; Bova G; Di Renzo M; Leo A; Cercignani M; Palazzuoli A; Auteri A; Bruni F
    Thromb Haemost; 2003 Sep; 90(3):476-82. PubMed ID: 12958617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etofibrate increases binding of low and high density lipoprotein to human platelets of patients with type II hyperlipoproteinemia.
    Virgolini I; Koller E; Li S; Yang Q; Banyai M; Rauscha F; Pidlich J; Pirker W; Sinzinger H
    Atherosclerosis; 1993 Sep; 102(2):217-26. PubMed ID: 8251008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia.
    Richter WO; Donner MG; Höfling B; Schwandt P
    Metabolism; 1998 Jul; 47(7):863-8. PubMed ID: 9667236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormalities of cholesterol-phospholipid composition in platelets and low-density lipoproteins of human hyperbetalipoproteinemia.
    Shattil SJ; Bennett JS; Colman RW; Cooper RA
    J Lab Clin Med; 1977 Feb; 89(2):341-53. PubMed ID: 188956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One year experience with a low density lipoprotein apheresis system.
    Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E
    Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
    Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
    G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary hemostasis in patients treated with LDL-apheresis for severe familiar hypercholesterolemia: a prospective pilot trial using PFA-100 analysis to rationalize therapeutic LDL-apheresis procedure.
    Blazek M; Blaha M; Pecka M; Blaha V; Masin V; Maly J
    Hematology; 2007 Dec; 12(6):571-6. PubMed ID: 17852459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein apheresis versus lipid lowering drugs in the treatment of severe hypercholesterolemia: four years' experience.
    Schiel R; Bambauer R; Müller U
    Artif Organs; 1996 Apr; 20(4):318-23. PubMed ID: 8860713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arachidonic acid of platelet phospholipids is decreased after extracorporeal removal of plasma low density lipoproteins in patients with familial hypercholesterolemia.
    Bräutigam R; Bräutigam C; Lorenz R; Richter WO; Engelmann B
    Atherosclerosis; 1997 May; 131(1):97-106. PubMed ID: 9180250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of plasmalogens in the enhanced resistance of LDL to copper-induced oxidation after LDL apheresis.
    Hahnel D; Thiery J; Brosche T; Engelmann B
    Arterioscler Thromb Vasc Biol; 1999 Oct; 19(10):2431-8. PubMed ID: 10521373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transitory decrease of platelet count, aggregation and adhesion after plasmapheresis and immunosorption procedures.
    Mazurov AV; Sinitsyn VE; Khashimov KhA; Konovalov GA; Vedernikov AV; Repin VS
    Thromb Res; 1987 Nov; 48(4):505-10. PubMed ID: 3328322
    [No Abstract]   [Full Text] [Related]  

  • 16. Low density lipoprotein apheresis improves regional myocardial perfusion in patients with hypercholesterolemia and extensive coronary artery disease. LDL-Apheresis Atherosclerosis Regression Study (LAARS).
    Aengevaeren WR; Kroon AA; Stalenhoef AF; Uijen GJ; van der Werf T
    J Am Coll Cardiol; 1996 Dec; 28(7):1696-704. PubMed ID: 8962554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-onset plasmapheresis and LDL-apheresis provide better disease control for pediatric homozygous familial hypercholesterolemia than HMG-CoA reductase inhibitors and ameliorate atherosclerosis.
    Dann EJ; Shamir R; Mashiach T; Shaoul R; Badian A; Stravets T; Kerzman Y; Finkelbaum S; Gaitini D; Lorber A; Bonstein L
    Transfus Apher Sci; 2013 Oct; 49(2):268-77. PubMed ID: 23791799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of low-density lipoprotein apheresis on coronary and carotid atherosclerosis and diabetic scleredema in patients with severe hypercholesterolemia.
    Koga N
    Ther Apher; 2001 Aug; 5(4):244-51. PubMed ID: 11724508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of HELP-LDL-apheresis on outcomes in patients with advanced coronary atherosclerosis and severe hypercholesterolemia.
    Park JW; Merz M; Braun P
    Atherosclerosis; 1998 Aug; 139(2):401-9. PubMed ID: 9712348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shear stress-dependent platelet function after LDL cholesterol apheresis.
    Spieker LE; Ruschitzka F; Badimon JJ; Noll G; Corti R
    Thromb Res; 2004; 113(6):395-8. PubMed ID: 15226094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.